• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Vanucizumab Antibody – Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5818763

Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and angiopoietin-2 (Ang-2) from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects. More details

Please Inquire
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Vanucizumab, Monoclonal Antibody
Full Product Name
Vanucizumab
Clonality
Monoclonal
Species Reactivity
VEGF-A and angiopoietin-2 (Ang-2)
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
1448221-05-3

Other Notes

Small volumes of anti-Vanucizumab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Vanucizumab purchase

MBS5818763 is an antibody targeting Vanucizumab. Reactive in VEGF-A and angiopoietin-2 (Ang-2).
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000